Learned taste aversion as a factor in cancer therapy
Smith, J.C.; Blumsack, J.T.
Cancer Treatment Reports 65(Suppl 5): 37-42
1981
ISSN/ISBN: 0361-5960 PMID: 7346161 Document Number: 178393
Document emailed within 1 workday
Related Documents
Smith, J.C.; Blumsack, J.T.; Bilek, F.S.; Spector, A.C.; Hollander, G.R.; Baker, D.L. 1984: Radiation-induced taste aversion as a factor in cancer therapy Cancer Treatment Reports 68(10): 1219-1227Buresová, O. 1978: Neocortico-amygdalar interaction in the conditioned taste aversion in rats Activitas Nervosa Superior 20(3): 224-230
Parshad, V.R. 1989: Conditioned taste aversion in lesser bandicoot rat, Bandicota bengalensis Indian Journal of Experimental Biology 27(11): 980-982
Czech, D.A.; Faubert, P. 1986: Triethyl lead attenuates feeding and drinking, and induces a conditioned taste aversion, in adult rats Neurobehavioral Toxicology and Teratology 8(6): 627-630
Willey, R. 1970: Aversion therapy. Case study Nursing Mirror and Midwives Journal 131(18): 33-34
1987: Aversion therapy. Council on Scientific Affairs JAMA 258(18): 2562-2566
Rakhawy, M.T. 1974: Phosphatases in the taste buds and taste bud-carrying papillae of the dog West African Journal of Pharmacology and Drug Research 2(1): 83P-84P
Magnasco, L.D.; Magnasco, A.J. 1985: Metallic taste associated with tetracycline therapy Clinical Pharmacy 4(4): 455-456
Morrow, M. 1998: Age as a selection factor for the local therapy of breast cancer? Journal of the American College of Surgeons 187(1): 94-95
Bartoshuk, L.M. 1979: Bitter taste of saccharin related to the genetic ability to taste the bitter substance 6-n-propylthiouracil Science 205(4409): 934-935
Schulte, E.; Holl, A. 1971: Investigation of taste buds of barbels in Corydoras paleatus Jenyns. I. Ultrastructure of the taste buds Zeitschrift für Zellforschung und mikroskopische Anatomie 120(3): 450-462
Mizukami, Y.; Sato, J.; Nihei, S.; Kashiwaba, M.; Kudo, K.; Okuyama, H.; Tamura, K. 2016: The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(8): 979-983
Olafsdottir, M.; Steinholtz, L.; Sjödén, P.O. 1986: Taste aversions in lung cancer patients treated with cytostatics Lakartidningen 83(3): 124-125; 128-129
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Oettgen, H.F. 1987: Interferons, interleukin-2 and tumor necrosis factor. new approaches to cancer therapy Arzneimittel-Forschung 37(2a): 251-255
Eshuis, M.; Verschoor, A.J.A.; Koster, T. 2011: A case of sweet taste perception caused by lung cancer-related hyponatraemia Nederlands Tijdschrift Voor Geneeskunde 155(26): A3150
Wirth, M. 1991: The value of interferons, interleukin-2 and tumor necrosis factor in the therapy of renal cell cancer Der Urologe. Ausg. a 30(2): 77-80
Fersis, N.; Smyczek-Gargya, B.; Armeanu, S.; Gagulic, E.; Pantic, L.; Relakis, K.; Friedrich, M.; Wallwiener, D. 2004: Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer European Journal of Gynaecological Oncology 25(1): 45-50
Gennari, L.; Belinsky, J.; Graziano, C.; Jankilevich, G. 2011: Hypertension as predictive factor in renal cell cancer treated with antiangiogenic therapy Medicina 71(3): 207-210
Tamura, T. 2002: Molecular target-based cancer therapy: epidermal growth factor receptor inhibitors Nihon Geka Gakkai Zasshi 103(2): 233-236